Perbedaan Emdeki Utama Tbk. dan Merck Tbk.: Emdeki Utama Tbk. diperdagangkan di Rp179 (kapitalisasi pasar 455,43 M, volume 24 jam 888,7 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 3,7× kapitalisasi pasar Emdeki Utama Tbk., dan Emdeki Utama Tbk. lebih aktif diperdagangkan (888,7 rb vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MDKI | MERK | |
|---|---|---|
Kapitalisasi Pasar | 455,43 M | 1,7 T |
Volume | 888,7 rb | 37,6 rb |
Lot | 8,89 rb | 376 |
Perputaran | 158,08 jt | 144,47 jt |
Harga Rata-rata | 177,88 | 3.842,23 |
Nilai Transaksi | 158,08 jt | 144,47 jt |
Harga Ekuilibrium Indikatif | 180 | 3.840 |
Volume Ekuilibrium Indikatif | 400 | 7 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Emdeki Utama (the Entity) was established based on Notarial Deed No. 33 of Hobropoerwanto, S.H., dated March 17, 1981.
Selengkapnya di halaman MDKI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →